+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Aerie Pharmaceuticals - logo

Aerie Pharmaceuticals is a company that focuses on the development and commercialization of therapies for the treatment of glaucoma and other eye diseases. The National Eye Institute expects the number of people in the United States suffering from glaucoma to reach 4.3 million by 2030. Aerie was founded in 2005 and went in public in 2013, raising $67 million in its IPO. Its product candidates include Rhopressa and Roclatan. The company is headquartered in Irvine, California.

Ocular Drug Delivery Global Market Report 2024 - Product Thumbnail Image

Ocular Drug Delivery Global Market Report 2024

  • Report
  • February 2024
  • 175 Pages
  • Global
From
From
From
From
From
Glaucoma Therapeutics - Global Strategic Business Report - Product Thumbnail Image

Glaucoma Therapeutics - Global Strategic Business Report

  • Report
  • November 2024
  • 193 Pages
  • Global
From
From
From
From
From
From
From
Loading Indicator